Domov › Rakovina prostaty › Minnesota › Minneapolis
Klinické štúdie Rakovina prostaty v meste Minneapolis, MN
23 štúdií pre Rakovina prostaty hľadá účastníkov v zariadeniach v meste Minneapolis a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
- Abbott-Northwestern Hospital, Minneapolis
- Hennepin County Medical Center, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · 5 míľ odtiaľ
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Prebieha náborFáza 2
- Health Partners Frauenshuh Cancer Center, Saint Louis Park · 5 míľ odtiaľ
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Prebieha náborFáza 2
- Hennepin County Medical Center, Minneapolis
A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
Prebieha náborFáza 1
- University Of Minnesota, Minneapolis
Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer
Prebieha náborFáza 1
- M Health Fairview Clinics and Surgery Center, Minneapolis
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Prebieha náborFáza 3
- HealthPartners Cancer Research Center-HealthPartners Frauenshuh Cancer Center ( Site 0072), Saint Louis Park · 5 míľ odtiaľ
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
Prebieha náborFáza 3
- Minnesota Oncology Hematology PA, Minneapolis
- University of Minnesota Medical Center Fairview, Minneapolis
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
Prebieha náborFáza 2
- Minneapolis VA Health Care System, Minneapolis, MN, Minneapolis
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Prebieha náborFáza 3
- HealthPartners Cancer Research Center-HealthPartners Frauenshuh Cancer Center ( Site 0032), Saint Louis Park · 5 míľ odtiaľ
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Prebieha náborFáza 3
- Abbott-Northwestern Hospital, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · 5 míľ odtiaľ
The Vanguard Study: Testing a New Way to Screen for Cancer
Prebieha náborVítaní zdravých dobrovoľníkov
- Minneapolis VA Medical Center, Minneapolis
Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer
Prebieha náborFáza 1/2
- Research Site, Minneapolis
A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide
Prebieha náborFáza 2
- Masonic Cancer Center, Minneapolis
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Prebieha náborFáza 3
- Abbott-Northwestern Hospital, Minneapolis
- Hennepin County Medical Center, Minneapolis
- Health Partners Inc, Minneapolis
- a 1 ďalších
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Prebieha náborFáza 1/2
- M Health Fairview University of Minnesota Medical Center, Minneapolis
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
Prebieha náborFáza 1
- University of Minnesota Medical Center, Minneapolis
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
Prebieha náborFáza 1
- Minnesota Oncology Hematology, Minneapolis
Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer
Prebieha náborFáza 1
- University of Minnesota, Minneapolis
Axelopran for Advanced Cancer in Patients Receiving Opioids
Prebieha náborFáza 2
- HealthPartners Frauenshuh Cancer Research Center, Saint Louis Park · 5 míľ odtiaľ
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
Prebieha náborFáza 3
- Abbott-Northwestern Hospital, Minneapolis
- Hennepin County Medical Center, Minneapolis
- Health Partners Inc, Minneapolis
- a 1 ďalších
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
- Allina Health Cancer Institute, Minneapolis
Vitamin D for Prostate Endocrine Therapy
Prebieha náborFáza 3
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · 5 míľ odtiaľ
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Prebieha náborFáza 3
- Hennepin County Medical Center, Minneapolis
- Health Partners Inc, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · 5 míľ odtiaľ
Štúdie Rakovina prostaty v iných mestách
- New York City, NY103 štúdií
- Houston, TX76 štúdií
- Los Angeles, CA61 štúdií
- Boston, MA59 štúdií
- St. Louis, MO46 štúdií
- Chicago, IL45 štúdií
- San Francisco, CA45 štúdií
- Philadelphia, PA44 štúdií
- Baltimore, MD43 štúdií
- Nashville, TN42 štúdií
- Seattle, WA42 štúdií
- Washington, DC38 štúdií
Iné štúdie v Minneapolis
- Rakovina prsníka27 štúdií
- Nemalobunkový karcinóm pľúc26 štúdií
- Rakovina vaječníkov24 štúdií
- Rakovina (všetky typy)22 štúdií
- Srdcové zlyhanie21 štúdií
- Rakovina pľúc20 štúdií
- Akútna myeloidná leukémia20 štúdií
- Kolorektálny karcinóm19 štúdií
- Rakovina endometria18 štúdií
- Parkinsonova choroba17 štúdií
- Kardiovaskulárne ochorenia15 štúdií
- Koronárne ochorenie srdca13 štúdií
Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.